The drugs industry closed the day up 0.9%. Cormedix Inc ( CRMD), Senesco Technologies Inc ( SNT), POZEN Inc ( POZN), and Complete Genomics Inc ( GNOM) were all decliners today within the drugs industry with Pharmasset Inc ( VRUS) being today's featured drugs loser. Pharmasset Inc fell $5.28 (-6.3%) to $78.24 on heavy volume. Throughout the day, 1.7 million shares of Pharmasset Inc exchanged hands as compared to its average daily volume of 1.1 million shares.

Pharmasset, Inc., a clinical-stage pharmaceutical company, focuses on discovering, developing, and commercializing novel drugs to treat viral infections. Pharmasset Inc has a market cap of $6.5 billion and is part of the health care sector. Shares are up 283.5% year to date as of the close of trading on Tuesday.

TheStreet Ratings rates Pharmasset as a sell. The company's weaknesses can be seen in multiple areas, such as its deteriorating net income, weak operating cash flow and feeble growth in its earnings per share.

On the positive front, Pacific Biosciences of California Inc ( PACB), Accelr8 Technology Corporation ( AXK), Uluru Inc ( ULU), and China Biologic Products Inc ( CBPO) were all gainers within the drugs industry with Johnson & Johnson ( JNJ) being today's featured drugs industry winner.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the drugs industry could consider SPDR S&P Pharmaceuticals ETF ( XPH) while those bearish on the drugs industry could consider ProShares UltraShort Nasdaq Biotech ( BIS).